From memory, the previous capital raise was to bridge a shortfall in funds until they had received R&D funds ($1ml). I find it difficult to see how they can fund themselves thru 1st QTR next year with under $3ml in cash when they are bringing products into the commercialization phase.
Extract below from Qtr report shows an net cash outflow per Qtr of over $2ml and only $2.2m in cash and refund of $1,39 from R&D. Its looks to me like a fund raising will need to happen before December 2023 if they have no other sources of revenue.
Financial Overview
At 30 June 2023, Firebrick held cash and cash equivalents of $2.355 million, compared with
$3.44 million at the end of the March quarter. Net cash outflow from operations for the quarter
was $2.08 million, 66.8% ($1.39m) of which was for R&D expenditure associated with the two
clinical trials being undertaken by the Company. Almost all of the R&D expenditure will be
eligible for the RDTI (R&D tax incentive), which is expected to be received in the September
quarter. The June quarter operating expenses were approximately in line with operating
expenditures in the previous two quarters
Add to My Watchlist
What is My Watchlist?
